Bile acids serum levels in patients with nonalcoholic fatty liver disease

Z Sh Minnullina , S V Kiyashko , O V Ryzhkova , R G Sayfutdinov

Kazan medical journal ›› 2015, Vol. 96 ›› Issue (3) : 354 -358.

PDF
Kazan medical journal ›› 2015, Vol. 96 ›› Issue (3) : 354 -358. DOI: 10.17750/KMJ2015-354
Theoretical and clinical medicine
research-article

Bile acids serum levels in patients with nonalcoholic fatty liver disease

Author information +
History +
PDF

Abstract

Aim. To estimate the blood levels of primary, secondary, tertiary and unconjugated bile acids in patients with non-alcoholic fatty liver disease.

Methods. The study included 74 patients with non-alcoholic fatty liver disease (males - 30, females - 44) and 51 healthy individuals (males - 14, females - 37). All patients underwent anthropometry and complete clinical, biochemical and instrumental examination (measuring the subcutaneous fat layer). 64 patients had hepatic steatosis, 10 - steatohepatitis. Serum levels of bile acids (primary: cholic, chenodeoxycholic; secondary: lithocholic, deoxycholic and tertiary: ursodeoxycholic) were measured by gas-liquid chromatography on «Chromos GC-1000» (Russia) scanner.

Results. Unconjugated primary, secondary and tertiary bile acids were detected in the blood of healthy individuals and patients with non-alcoholic fatty liver disease. In healthy individuals, there were no gender differences found in the bile acids levels. Patients with non-alcoholic fatty liver disease had higher level of bile acids compared to healthy controls. There was a significant difference in the concentrations of secondary and tertiary bile acids in patients with hepatic steatosis and steatohepatitis.

Conclusion. Blood bile acids levels were significantly higher in patients with non-alcoholic fatty liver disease than in healthy individuals. At steatohepatitis, females had higher levels of cholic, chenodeoxycholic and deoxycholic acids and lower levels of lithocholic and ursodeoxycholic acids compared to males. Significant difference in patients with hepatic steatosis and steatohepatitis was revealed only in levels of secondary and tertiary bile acids.

Keywords

unconjugated bile acids / blood / non-alcoholic fatty liver disease / hepatic steatosis / steatohepatitis

Cite this article

Download citation ▾
Z Sh Minnullina, S V Kiyashko, O V Ryzhkova, R G Sayfutdinov. Bile acids serum levels in patients with nonalcoholic fatty liver disease. Kazan medical journal, 2015, 96(3): 354-358 DOI:10.17750/KMJ2015-354

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Абдурахманов Д.Т. Алкогольная болезнь печени // Рос. ж. гастроэнтерол., гепатол., колопроктол. - 2007. - Т. 17, №6. - С. 1-11.

[2]

Буеверов А.О., Богомолов П.О., Маевская M.B. Патогенетическое лечение неалкогольного стеатогепатита: обоснование, эффективность, безопасность // Тер. архив. - 2007. - Т. 79, №8. - С. 88-92.

[3]

Корнеева О.Н., Драпкина О.М. Неалкогольная жировая болезнь печени у пациентов с метаболическим синдромом // Рос. ж. гастроэнтерол., гепатол., колопроктол (приложение №29). - 2007. - Т. 17, №6, прил. 29. - С. 65.

[4]

Angulo P., Keach J.C., Batts K.P., Lindor K.D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis // Hepatology. - 2009. -Vol. 30. - P. 1356-1362. http://dx.doi.org/10.1002/hep.510300604

[5]

Leuschner U. Non-alcoholic Steatohepatitis (NASH). - Freiburg, 2012. - 44 p.

[6]

Magnusson M., Fischler B., Svensson J. et al. Bile acids and coagulation factors: paradoxical association in children with chronic liver disease // Eur. J. Gastroenterol. Hepatol. - 2013. - Vol. 25, N 2. - Р. 152-158. http://dx.doi.org/10.1097/MEG.0b013e32835a86f3

[7]

Neuschwander-Tetri B.A., Caldwell S.H. Nonalcoholic steatohepatitis: Summary of an AASLD Single Conference // Hepatology. - 2003. - Vol. 37, N 5. - P. 1202-1209. http://dx.doi.org/10.1053/jhep.2003.50193

[8]

Parry G.J., Rodrigues C.M., Aranha M.M. et al. Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic acid in patients with amyotrophic lateral sclerosis // Clin. Neuropharmacol. - 2010. - Vol. 33, N 1. - P. 17-21. http://dx.doi.org/10.1097/WNF.0b013e3181c47569

[9]

Rainer P.P., Primessnig U., Harenkamp S. et al. Bile acids induce arrhythmias in human atrial myocardium - implications for altered serum bile acid composition in patients with atrial fibrillation // Heart. - 2013. - Vol. 99, N 22. - P. 1685-1692. http://dx.doi.org/10.1136/heartjnl-2013-304163

[10]

Taylor D.R., Alaghband-Zadeh J., Cross G.F. et al. Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2 // PLoS One. - 2014. - Vol. 9, N 4. - P. 93 540. http://dx.doi.org/10.1371/journal.pone.0093540

[11]

Wang F., Zhao C., Tian Y., Yin Y. Effect of high blood levels of bile acid on respiratory functions of New Zealand rabbits // Nan Fang Yi Ke Da Xue Xue Bao. - 2013 - Vol. 33, N 8. - Р. 1181-1184. http://dx.doi.org/10.3969/j.issn.1673-4254.2013.08.18

RIGHTS & PERMISSIONS

Minnullina Z.S., Kiyashko S.V., Ryzhkova O.V., Sayfutdinov R.G.

AI Summary AI Mindmap
PDF

109

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/